Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LPCAT2 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-08 |
mRNA | FAM83B | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-06 |
mRNA | GALNT3 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-07 |
mRNA | SOX10 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0003 |
mRNA | S100A9 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
mRNA | DSG2 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-06 |
mRNA | KLC3 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-07 |
mRNA | TGFA | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-07 |
mRNA | PKP3 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-06 |
mRNA | PHLDA3 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-08 |